Not applicableUnknownNCT04792957What this trial is testingJAK-STAT Signaling Pathway in Pyoderma GangrenosumWho this might be right forPyoderma GangrenosumHidradenitis SuppurativaPsoriasis Dokuz Eylul University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444684What this trial is testingEvaluate SHR-1139 Injection in Patients With Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableWithdrawnNCT05984654What this trial is testingAutologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Ohio State University
Testing effectiveness (Phase 2)Study completedNCT02733094What this trial is testingSingle-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Technical University of Munich 8
Large-scale testing (Phase 3)Ended earlyNCT02315417What this trial is testingAn Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum XOMA (US) LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT06092216What this trial is testingSpesolimab in Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Icahn School of Medicine at Mount Sinai 5
Very early researchWithdrawnNCT05821374What this trial is testingDeucravacitinib in PGWho this might be right forPyoderma Gangrenosum Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06624670What this trial is testingTest Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Boehringer Ingelheim 90
Testing effectiveness (Phase 2)WithdrawnNCT00730717What this trial is testingSafety and Efficacy Study of Humira in Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Wright State University
Not applicableStudy completedNCT00791557What this trial is testingOpen Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseWho this might be right forPyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more University Hospitals Cleveland Medical Center 2
Large-scale testing (Phase 3)Ended earlyNCT02318914What this trial is testingA 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum XOMA (US) LLC 15
Testing effectiveness (Phase 2)WithdrawnNCT00690846What this trial is testingStudy to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Wake Forest University Health Sciences
Large-scale testing (Phase 3)Ended earlyNCT05964413What this trial is testingPhase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum InflaRx GmbH 54
Testing effectiveness (Phase 2)Study completedNCT03137160What this trial is testingAn Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Ohio State University 4
Post-approval studies (Phase 4)Ended earlyNCT05120726What this trial is testingA Novel Therapeutic Treatment of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Louisiana State University Health Sciences Center in New Orleans 5
Not applicableUnknownNCT03636737What this trial is testingStudy on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Assistance Publique Hopitaux De Marseille 140
Testing effectiveness (Phase 2)WithdrawnNCT04274166What this trial is testingSecukinumab for the Inflammatory Phase of Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Wake Forest University Health Sciences
Large-scale testing (Phase 3)Ended earlyNCT05343754What this trial is testingHyperbaric Oxygen Therapy for Pyoderma GangrenosumWho this might be right forPyoderma Gangrenosum Erasmus Medical Center 3
Large-scale testing (Phase 3)Study completedNCT03311464What this trial is testingA Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in JapanWho this might be right forPyoderma Gangrenosum AbbVie 22
Early research (Phase 1)Study completedNCT03386942What this trial is testingMORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid TumorsWho this might be right forSolid Tumors Eisai Inc. 82